Zydus Medtech brings Brazil’s breakthrough heart valve tech to India and Europe in global expansion move
Zydus Medtech signs global licensing deal with Braile Biomedica to commercialise next-gen TAVI heart valve tech across India and Europe. Read more. Read More
Zydus Lifesciences, EaseMyTrip, and JTL Industries slump as Indian equities face renewed volatility
Zydus Lifesciences, EaseMyTrip and JTL Industries led the top stock losers in India on April 16, as markets corrected sharply on macro concerns. Read the ... Read More
Zydus wins FDA nod for DMD drug Jaythari—what it means for rare disease treatment and its stock
Find out how Zydus Lifesciences is expanding rare disease care and investor value with USFDA-approved Jaythari tablets for Duchenne muscular dystrophy. Read More
Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light
Zydus Lifesciences gains USFDA approval for Apalutamide Tablets, 60 mg, expanding its oncology generics portfolio. Find out what this means for investors. Read More
Zynext Ventures expands biotech portfolio with Illexcor’s sickle cell drug investment
Zynext Ventures USA LLC (Zynext Ventures), the venture capital division of Zydus Lifesciences, has announced a strategic investment in Illexcor Therapeutics, a biopharmaceutical company pioneering ... Read More
Zydus Lifesciences just launched a flu shot for the latest virus strain—should you get it?
Zydus Lifesciences has introduced VaxiFlu-4, India’s first quadrivalent inactivated influenza vaccine designed to combat the latest flu strains for the 2025 Southern Hemisphere flu season. ... Read More
Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge
Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by strong revenue growth momentum, expansion in key ... Read More
Zydus Lifesciences chairman Pankaj Patel honoured with Padma Bhushan
In a proud moment for the Indian lifesciences industry, Pankaj R. Patel, Chairman of Zydus Lifesciences Limited, has been awarded the prestigious Padma Bhushan. Conferred ... Read More
Zydus Lifesciences gets FDA approval for Phase 2b ALS trial of Usnoflast
Zydus Lifesciences, a global leader in pharmaceutical innovation, has received approval from the United States Food and Drug Administration (USFDA) to commence Phase II(b) clinical ... Read More
Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More